Free Webinar | 17 November 2026 |  8 – 9pm (AEST)

Join us in November to understand Preeclampsia Research: Where are we now and where are we heading?

Dr Fateme Akhlaghi will discuss “Towards Earlier Detection of Preeclampsia: Could a Simple Finger-Prick Test Make a Difference?”
In this presentation, Dr Akhlaghi will share how her team at RMIT University is developing sensor technology with the potential to enable rapid finger-prick testing at the point of care. She will discuss the team’s early findings, the next steps towards clinical application, and how her own experience with preeclampsia inspired this research.

Dr Jennifer Yo will discuss “Beyond delivery: kidney risk, follow-up and intervention after preeclampsia.”
This presentation will explore the long-term risk of chronic kidney disease following preeclampsia and the initiatives being undertaken at Monash Health and Monash University to address this risk.

Professor Shireen Meher will discuss “Global roadmap for hypertensive disorders of pregnancy from 2026 to 2035 and beyond.”
This discussion will highlight key findings and recommendations from the recently launched WHO Global Roadmap for reducing maternal and perinatal deaths and morbidity associated with hypertensive disorders of pregnancy. Professor Meher will also encourage reflection on how these recommendations can be adapted and implemented within the Australian context.

Register below:

Preeclampsia Research: Where are we now and where are we heading?
Name
Name
First
Last
Membership Status
How did you hear about this event?

Meet our Presenters
Dr Fateme Akhlaghi Dr Jennifer Yo Professor Shireen Meher
Dr Fateme Akhlaghi is a research scientist at RMIT University with a PhD in Chemistry, specialising in biosensors and diagnostic technologies. Her research focuses on developing rapid, accessible diagnostic technologies, with a particular interest in women’s health. Inspired by her own experience with preeclampsia, she is working to advance new approaches for earlier detection of the condition. She is also a co-founder of AnaVue Health, a women’s health startup dedicated to making innovative diagnostic technologies more accessible and translating research into real-world impact. Dr Jennifer Yo is an early-career nephrologist at Monash Health, Melbourne, with a particular interest in the intersection of nephrology and women’s health. She completed a post-fellowship training programme in obstetric medicine at the University of Toronto, Canada, and holds a Master of Public Health in Epidemiology from Harvard University and a PhD from Monash University, where she investigated the role of endothelial dysfunction and transplant immunosuppression in the pathogenesis of preeclampsia. She established and leads the Obstetric Nephrology Clinic at Monash Health and is a recipient of the Sylvia and Charles Viertel Clinical Investigator Award for 2027. Shireen Meher was appointed as Professor in Maternal Fetal Medicine at the University of Sydney in October 2024. She is based at the Nepean Clinical School, where she leads the obstetric research programme. She is a member of the leadership team of the Clinical Academic Group for Sydney Health Partners and the University of Sydney’s Reproduction and Perinatal Centre. Professor Meher did her undergraduate medical education in India, and completed her clinical and academic training in Obstetrics and Gynaecology in the UK. She did her MD research degree on prevention of pre-eclampsia with the University of Liverpool, and acquired subspecialist accreditation in Maternal Fetal Medicine at Imperial College, London.Before moving to Australia, she worked as a clinical academic and consultant obstetrician in the NHS (UK), leading on a number of NIHR funded research projects and delivering a service in high risk obstetrics, mutliple pregnancy, and fetal therapy interventions at the Birmingham Women’s Hospital.